Marksans Pharma LimitedNSE: MARKSANS

Press Release Sep 23 2025

· Issued by Marksans Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-23-2025-15

Marksans Pharma Limited has informed the Exchange regarding a press release dated September 23, 2025, titled "Marksans Pharma Ltd's subsidiary Relonchem Limited in UK received marketing authorisation for its products from UK MHRA.".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases